BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18290877)

  • 1. Distinct role of adrenoceptor subtypes in cardiac adaptation to chronic pressure overload.
    Du XJ
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):355-60. PubMed ID: 18290877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction.
    Du XJ; Fang L; Gao XM; Kiriazis H; Feng X; Hotchkin E; Finch AM; Chaulet H; Graham RM
    J Mol Cell Cardiol; 2004 Nov; 37(5):979-87. PubMed ID: 15522275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic alpha(2)-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload.
    Gilsbach R; Schneider J; Lother A; Schickinger S; Leemhuis J; Hein L
    Cardiovasc Res; 2010 Jun; 86(3):432-42. PubMed ID: 20083574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained augmentation of cardiac alpha1A-adrenergic drive results in pathological remodeling with contractile dysfunction, progressive fibrosis and reactivation of matricellular protein genes.
    Chaulet H; Lin F; Guo J; Owens WA; Michalicek J; Kesteven SH; Guan Z; Prall OW; Mearns BM; Feneley MP; Steinberg SF; Graham RM
    J Mol Cell Cardiol; 2006 Apr; 40(4):540-52. PubMed ID: 16516910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pressure overload causes cardiac hypertrophy in beta1-adrenergic and beta2-adrenergic receptor double knockout mice.
    Palazzesi S; Musumeci M; Catalano L; Patrizio M; Stati T; Michienzi S; Di Certo MG; Mattei E; Vitelli L; Marano G
    J Hypertens; 2006 Mar; 24(3):563-71. PubMed ID: 16467660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon.
    Klein G; Schaefer A; Hilfiker-Kleiner D; Oppermann D; Shukla P; Quint A; Podewski E; Hilfiker A; Schröder F; Leitges M; Drexler H
    Circ Res; 2005 Apr; 96(7):748-55. PubMed ID: 15761199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart adrenoceptor gene expression and binding sites in the human failing heart.
    Fischer V; Gabauer I; Tillinger A; Novakova M; Pechan I; Krizanova O; Kvetnanský R; Myslivecek J
    Ann N Y Acad Sci; 2008 Dec; 1148():400-8. PubMed ID: 19120134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenergic pathways and left ventricular remodeling.
    Dorn GW
    J Card Fail; 2002 Dec; 8(6 Suppl):S370-3. PubMed ID: 12555147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of JunD promotes pressure overload-induced apoptosis, hypertrophic growth, and angiogenesis in the heart.
    Hilfiker-Kleiner D; Hilfiker A; Kaminski K; Schaefer A; Park JK; Michel K; Quint A; Yaniv M; Weitzman JB; Drexler H
    Circulation; 2005 Sep; 112(10):1470-7. PubMed ID: 16129800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac alpha 1-adrenergic drive in pathological remodelling.
    Woodcock EA; Du XJ; Reichelt ME; Graham RM
    Cardiovasc Res; 2008 Feb; 77(3):452-62. PubMed ID: 18032391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulated overexpression of the A1-adenosine receptor in mice results in adverse but reversible changes in cardiac morphology and function.
    Funakoshi H; Chan TO; Good JC; Libonati JR; Piuhola J; Chen X; MacDonnell SM; Lee LL; Herrmann DE; Zhang J; Martini J; Palmer TM; Sanbe A; Robbins J; Houser SR; Koch WJ; Feldman AM
    Circulation; 2006 Nov; 114(21):2240-50. PubMed ID: 17088462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice.
    Bisognano JD; Weinberger HD; Bohlmeyer TJ; Pende A; Raynolds MV; Sastravaha A; Roden R; Asano K; Blaxall BC; Wu SC; Communal C; Singh K; Colucci W; Bristow MR; Port DJ
    J Mol Cell Cardiol; 2000 May; 32(5):817-30. PubMed ID: 10775486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterozygous alpha 2C-adrenoceptor-deficient mice develop heart failure after transverse aortic constriction.
    Gilsbach R; Brede M; Beetz N; Moura E; Muthig V; Gerstner C; Barreto F; Neubauer S; Vieira-Coelho MA; Hein L
    Cardiovasc Res; 2007 Sep; 75(4):728-37. PubMed ID: 17597596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockout of beta(1)- and beta(2)-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis.
    Kiriazis H; Wang K; Xu Q; Gao XM; Ming Z; Su Y; Moore XL; Lambert G; Gibbs ME; Dart AM; Du XJ
    Br J Pharmacol; 2008 Feb; 153(4):684-92. PubMed ID: 18193078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential cardiovascular regulatory activities of the alpha 1B- and alpha 1D-adrenoceptor subtypes.
    Chalothorn D; McCune DF; Edelmann SE; Tobita K; Keller BB; Lasley RD; Perez DM; Tanoue A; Tsujimoto G; Post GR; Piascik MT
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1045-53. PubMed ID: 12649302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload.
    Grieve DJ; Byrne JA; Siva A; Layland J; Johar S; Cave AC; Shah AM
    J Am Coll Cardiol; 2006 Feb; 47(4):817-26. PubMed ID: 16487851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis.
    Xu Q; Lekgabe ED; Gao XM; Ming Z; Tregear GW; Dart AM; Bathgate RA; Samuel CS; Du XJ
    Endocrinology; 2008 Feb; 149(2):476-82. PubMed ID: 17991721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice.
    Franco V; Chen YF; Feng JA; Li P; Wang D; Hasan E; Oparil S; Perry GJ
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):773-9. PubMed ID: 16922805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant.
    van Empel VP; Bertrand AT; van Oort RJ; van der Nagel R; Engelen M; van Rijen HV; Doevendans PA; Crijns HJ; Ackerman SL; Sluiter W; De Windt LJ
    J Am Coll Cardiol; 2006 Aug; 48(4):824-32. PubMed ID: 16904556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide synthase 2 and pressure-overload-induced left ventricular remodelling in mice.
    Hataishi R; Rodrigues AC; Morgan JG; Ichinose F; Derumeaux G; Bloch KD; Picard MH; Scherrer-Crosbie M
    Exp Physiol; 2006 May; 91(3):633-9. PubMed ID: 16527862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.